- What is Integra Holdings' primary investment focus?
- Integra Holdings is a healthcare investment company with an exclusive first right to examine innovations and intellectual property from the Hebrew University of Jerusalem. Their focus is on biopharmaceuticals, medical diagnostics, and devices.
- Which stages of investment does Integra Holdings typically engage in?
- Integra Holdings invests across various stages, including Pre-Seed, Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
- Can you name some of Integra Holdings' notable portfolio companies?
- Integra Holdings' portfolio includes companies such as Atox Bio, which focuses on immunomodulators, and SpliSense, which develops RNA-based treatments for genetic diseases.
- What is the most recent investment round Integra Holdings participated in?
- Integra Holdings participated in an investment round in April 2024.
- What is Integra Holdings' approach to supporting its portfolio companies?
- Integra Holdings provides know-how and support to its portfolio companies from inception to commercialization, leveraging its extensive industry network and employing multidisciplinary teams of experts.
- Who are the key shareholders of Integra Holdings?
- Integra Holdings' shareholders include Yissum, Temasek, Invatech Holdings, Arie Capital, Guangxi Wuzhou Pharmaceutical Group Co Ltd, and Israeli institutional funds such as the Israeli Teachers and Kindergarten Study funds.
- What is the total amount raised by portfolio company Atox Bio?
- Atox Bio, a portfolio company of Integra Holdings, has raised $64.85 million in funding.
- What is the total amount raised by portfolio company SpliSense?
- SpliSense, a portfolio company of Integra Holdings, has raised $41.5 million in funding.
